vs
CIVISTA BANCSHARES, INC.（CIVB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是CIVISTA BANCSHARES, INC.的1.5倍（$69.8M vs $47.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 31.7%，领先352.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 11.3%）
Civista Bancshares Inc.是一家总部位于美国的银行控股公司，主要在中西部地区运营，面向零售客户、本地中小企业及社区群体提供个人与商业银行服务，包括存款账户、各类贷款产品及财富管理解决方案。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CIVB vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.5倍
$47.3M
净利率更高
RIGL
高出352.3%
31.7%
两年增速更快
RIGL
近两年复合增速
11.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.3M | $69.8M |
| 净利润 | $15.0M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 31.7% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | 47.4% | 1769.2% |
| 每股收益（稀释后） | $0.72 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CIVBRIGL
| Q1 26 | $47.3M | — | ||
| Q4 25 | $46.3M | $69.8M | ||
| Q3 25 | $44.2M | $69.5M | ||
| Q2 25 | $41.4M | $101.7M | ||
| Q1 25 | $40.6M | $53.3M | ||
| Q4 24 | $40.4M | $57.6M | ||
| Q3 24 | $39.3M | $55.3M | ||
| Q2 24 | $38.1M | $36.8M |
净利润CIVBRIGL
| Q1 26 | $15.0M | — | ||
| Q4 25 | — | $268.1M | ||
| Q3 25 | $12.8M | $27.9M | ||
| Q2 25 | $11.0M | $59.6M | ||
| Q1 25 | $10.2M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $8.4M | $12.4M | ||
| Q2 24 | $7.1M | $-1.0M |
毛利率CIVBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率CIVBRIGL
| Q1 26 | — | — | ||
| Q4 25 | 31.8% | 33.2% | ||
| Q3 25 | 35.4% | 40.9% | ||
| Q2 25 | 31.1% | 60.1% | ||
| Q1 25 | 29.4% | 23.9% | ||
| Q4 24 | 28.2% | 28.9% | ||
| Q3 24 | 25.2% | 25.4% | ||
| Q2 24 | 21.2% | 1.2% |
净利率CIVBRIGL
| Q1 26 | 31.7% | — | ||
| Q4 25 | — | 384.0% | ||
| Q3 25 | 28.9% | 40.2% | ||
| Q2 25 | 26.6% | 58.6% | ||
| Q1 25 | 25.0% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 21.3% | 22.5% | ||
| Q2 24 | 18.5% | -2.8% |
每股收益（稀释后）CIVBRIGL
| Q1 26 | $0.72 | — | ||
| Q4 25 | $0.59 | $14.11 | ||
| Q3 25 | $0.68 | $1.46 | ||
| Q2 25 | $0.71 | $3.28 | ||
| Q1 25 | $0.66 | $0.63 | ||
| Q4 24 | $0.62 | $0.82 | ||
| Q3 24 | $0.53 | $0.70 | ||
| Q2 24 | $0.45 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $553.9M | $391.5M |
| 总资产 | $4.3B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CIVBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M |
总债务CIVBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益CIVBRIGL
| Q1 26 | $553.9M | — | ||
| Q4 25 | $543.5M | $391.5M | ||
| Q3 25 | $499.0M | $117.6M | ||
| Q2 25 | $404.1M | $81.9M | ||
| Q1 25 | $397.4M | $18.6M | ||
| Q4 24 | $388.5M | $3.3M | ||
| Q3 24 | $394.4M | $-14.6M | ||
| Q2 24 | $373.8M | $-29.9M |
总资产CIVBRIGL
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $513.6M | ||
| Q3 25 | $4.1B | $242.5M | ||
| Q2 25 | $4.2B | $206.7M | ||
| Q1 25 | $4.1B | $176.0M | ||
| Q4 24 | $4.1B | $164.0M | ||
| Q3 24 | $4.1B | $139.4M | ||
| Q2 24 | $4.0B | $128.4M |
负债/权益比CIVBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CIVBRIGL
| Q1 26 | — | — | ||
| Q4 25 | $43.3M | $22.0M | ||
| Q3 25 | $19.0M | $24.0M | ||
| Q2 25 | $11.1M | $30.5M | ||
| Q1 25 | $3.6M | $-893.0K | ||
| Q4 24 | $48.2M | $14.5M | ||
| Q3 24 | $12.9M | $21.7M | ||
| Q2 24 | $12.2M | $302.0K |
自由现金流CIVBRIGL
| Q1 26 | — | — | ||
| Q4 25 | $42.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $3.5M | — | ||
| Q4 24 | $44.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率CIVBRIGL
| Q1 26 | — | — | ||
| Q4 25 | 90.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 109.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度CIVBRIGL
| Q1 26 | — | — | ||
| Q4 25 | 2.5% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率CIVBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.49× | 0.86× | ||
| Q2 25 | 1.01× | 0.51× | ||
| Q1 25 | 0.36× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 1.54× | 1.75× | ||
| Q2 24 | 1.73× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CIVB
| Net Interest Income | $37.8M | 80% |
| Noninterest Income | $9.4M | 20% |
RIGL
暂无分部数据
